Encephalitis Virus Vaccine Market
1 Study Coverage
1.1 Japanese Encephalitis Virus Vaccine Product Introduction
1.2 Market by Type
1.2.1 Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Inactivated Vaccine
1.2.3 Live Attenuated Vaccine
1.3 Market by Application
1.3.1 Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Public
1.3.3 Private
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Japanese Encephalitis Virus Vaccine Sales Estimates and Forecasts 2017-2028
2.2 Global Japanese Encephalitis Virus Vaccine Revenue Estimates and Forecasts 2017-2028
2.3 Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Japanese Encephalitis Virus Vaccine Sales by Region
2.4.1 Global Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022)
2.4.2 Global Sales Japanese Encephalitis Virus Vaccine by Region (2023-2028)
2.5 Global Japanese Encephalitis Virus Vaccine Revenue by Region
2.5.1 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022)
2.5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers
3.1.1 Global Top Japanese Encephalitis Virus Vaccine Manufacturers by Sales (2017-2022)
3.1.2 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Japanese Encephalitis Virus Vaccine in 2021
3.2 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers
3.2.1 Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (2017-2022)
3.2.2 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Japanese Encephalitis Virus Vaccine Revenue in 2021
3.3 Global Japanese Encephalitis Virus Vaccine Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Japanese Encephalitis Virus Vaccine Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Japanese Encephalitis Virus Vaccine Sales by Type
4.1.1 Global Japanese Encephalitis Virus Vaccine Historical Sales by Type (2017-2022)
4.1.2 Global Japanese Encephalitis Virus Vaccine Forecasted Sales by Type (2023-2028)
4.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
4.2 Global Japanese Encephalitis Virus Vaccine Revenue by Type
4.2.1 Global Japanese Encephalitis Virus Vaccine Historical Revenue by Type (2017-2022)
4.2.2 Global Japanese Encephalitis Virus Vaccine Forecasted Revenue by Type (2023-2028)
4.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
4.3 Global Japanese Encephalitis Virus Vaccine Price by Type
4.3.1 Global Japanese Encephalitis Virus Vaccine Price by Type (2017-2022)
4.3.2 Global Japanese Encephalitis Virus Vaccine Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Japanese Encephalitis Virus Vaccine Sales by Application
5.1.1 Global Japanese Encephalitis Virus Vaccine Historical Sales by Application (2017-2022)
5.1.2 Global Japanese Encephalitis Virus Vaccine Forecasted Sales by Application (2023-2028)
5.1.3 Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
5.2 Global Japanese Encephalitis Virus Vaccine Revenue by Application
5.2.1 Global Japanese Encephalitis Virus Vaccine Historical Revenue by Application (2017-2022)
5.2.2 Global Japanese Encephalitis Virus Vaccine Forecasted Revenue by Application (2023-2028)
5.2.3 Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
5.3 Global Japanese Encephalitis Virus Vaccine Price by Application
5.3.1 Global Japanese Encephalitis Virus Vaccine Price by Application (2017-2022)
5.3.2 Global Japanese Encephalitis Virus Vaccine Price Forecast by Application (2023-2028)
6 North America
6.1 North America Japanese Encephalitis Virus Vaccine Market Size by Type
6.1.1 North America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
6.1.2 North America Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
6.2 North America Japanese Encephalitis Virus Vaccine Market Size by Application
6.2.1 North America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
6.2.2 North America Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
6.3 North America Japanese Encephalitis Virus Vaccine Market Size by Country
6.3.1 North America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
6.3.2 North America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
6.3.3 the United States
6.3.4 Canada
7 Europe
7.1 Europe Japanese Encephalitis Virus Vaccine Market Size by Type
7.1.1 Europe Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
7.1.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
7.2 Europe Japanese Encephalitis Virus Vaccine Market Size by Application
7.2.1 Europe Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
7.2.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
7.3 Europe Japanese Encephalitis Virus Vaccine Market Size by Country
7.3.1 Europe Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
7.3.2 Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 UK
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Type
8.1.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
8.1.2 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
8.2 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Application
8.2.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
8.2.2 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
8.3 Asia Pacific Japanese Encephalitis Virus Vaccine Market Size by Region
8.3.1 Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2017-2028)
8.3.2 Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Japanese Encephalitis Virus Vaccine Market Size by Type
9.1.1 Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
9.1.2 Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
9.2 Latin America Japanese Encephalitis Virus Vaccine Market Size by Application
9.2.1 Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
9.2.2 Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
9.3 Latin America Japanese Encephalitis Virus Vaccine Market Size by Country
9.3.1 Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
9.3.2 Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Type
10.1.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Type (2017-2028)
10.1.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2028)
10.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Application
10.2.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Application (2017-2028)
10.2.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2028)
10.3 Middle East and Africa Japanese Encephalitis Virus Vaccine Market Size by Country
10.3.1 Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2017-2028)
10.3.2 Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Research Foundation for Microbial Diseases of Osaka University
11.1.1 Research Foundation for Microbial Diseases of Osaka University Corporation Information
11.1.2 Research Foundation for Microbial Diseases of Osaka University Overview
11.1.3 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Research Foundation for Microbial Diseases of Osaka University Recent Developments
11.2 Valneva Austria GmbH
11.2.1 Valneva Austria GmbH Corporation Information
11.2.2 Valneva Austria GmbH Overview
11.2.3 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Valneva Austria GmbH Recent Developments
11.3 Chengdu Institute
11.3.1 Chengdu Institute Corporation Information
11.3.2 Chengdu Institute Overview
11.3.3 Chengdu Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Chengdu Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Chengdu Institute Recent Developments
11.4 Liaoning Dacheng
11.4.1 Liaoning Dacheng Corporation Information
11.4.2 Liaoning Dacheng Overview
11.4.3 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Liaoning Dacheng Recent Developments
11.5 Wuhan Institute
11.5.1 Wuhan Institute Corporation Information
11.5.2 Wuhan Institute Overview
11.5.3 Wuhan Institute Japanese Encephalitis Virus Vaccine Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Wuhan Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Wuhan Institute Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Japanese Encephalitis Virus Vaccine Industry Chain Analysis
12.2 Japanese Encephalitis Virus Vaccine Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Japanese Encephalitis Virus Vaccine Production Mode & Process
12.4 Japanese Encephalitis Virus Vaccine Sales and Marketing
12.4.1 Japanese Encephalitis Virus Vaccine Sales Channels
12.4.2 Japanese Encephalitis Virus Vaccine Distributors
12.5 Japanese Encephalitis Virus Vaccine Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Japanese Encephalitis Virus Vaccine Industry Trends
13.2 Japanese Encephalitis Virus Vaccine Market Drivers
13.3 Japanese Encephalitis Virus Vaccine Market Challenges
13.4 Japanese Encephalitis Virus Vaccine Market Restraints
14 Key Findings in The Global Japanese Encephalitis Virus Vaccine Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Inactivated Vaccine
Table 3. Major Manufacturers of Live Attenuated Vaccine
Table 4. Global Japanese Encephalitis Virus Vaccine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Japanese Encephalitis Virus Vaccine Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 7. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2017-2022)
Table 8. Global Japanese Encephalitis Virus Vaccine Sales by Region (2023-2028) & (K Units)
Table 9. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2023-2028)
Table 10. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2017-2022)
Table 12. Global Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region (2023-2028)
Table 14. Global Japanese Encephalitis Virus Vaccine Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Japanese Encephalitis Virus Vaccine Sales Share by Manufacturers (2017-2022)
Table 16. Global Japanese Encephalitis Virus Vaccine Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Japanese Encephalitis Virus Vaccine Revenue Share by Manufacturers (2017-2022)
Table 18. Japanese Encephalitis Virus Vaccine Price by Manufacturers (2017-2022) &(USD/Unit)
Table 19. Global Japanese Encephalitis Virus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Japanese Encephalitis Virus Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Japanese Encephalitis Virus Vaccine as of 2021)
Table 21. Japanese Encephalitis Virus Vaccine Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Japanese Encephalitis Virus Vaccine Product Offered
Table 23. Date of Manufacturers Enter into Japanese Encephalitis Virus Vaccine Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 26. Global Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 27. Global Japanese Encephalitis Virus Vaccine Sales Share by Type (2017-2022)
Table 28. Global Japanese Encephalitis Virus Vaccine Sales Share by Type (2023-2028)
Table 29. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 30. Global Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 31. Global Japanese Encephalitis Virus Vaccine Revenue Share by Type (2017-2022)
Table 32. Global Japanese Encephalitis Virus Vaccine Revenue Share by Type (2023-2028)
Table 33. Japanese Encephalitis Virus Vaccine Price by Type (2017-2022) & (USD/Unit)
Table 34. Global Japanese Encephalitis Virus Vaccine Price Forecast by Type (2023-2028) & (USD/Unit)
Table 35. Global Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 36. Global Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 37. Global Japanese Encephalitis Virus Vaccine Sales Share by Application (2017-2022)
Table 38. Global Japanese Encephalitis Virus Vaccine Sales Share by Application (2023-2028)
Table 39. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Japanese Encephalitis Virus Vaccine Revenue Share by Application (2017-2022)
Table 42. Global Japanese Encephalitis Virus Vaccine Revenue Share by Application (2023-2028)
Table 43. Japanese Encephalitis Virus Vaccine Price by Application (2017-2022) & (USD/Unit)
Table 44. Global Japanese Encephalitis Virus Vaccine Price Forecast by Application (2023-2028) & (USD/Unit)
Table 45. North America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 46. North America Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 47. North America Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 48. North America Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 49. North America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 50. North America Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 51. North America Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 54. North America Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 55. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 58. Europe Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 59. Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 60. Europe Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 61. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 62. Europe Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 63. Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 66. Europe Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 67. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 70. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 71. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 72. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 73. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Japanese Encephalitis Virus Vaccine Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 82. Latin America Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 83. Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 84. Latin America Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 85. Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Type (2017-2022) & (K Units)
Table 94. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Type (2023-2028) & (K Units)
Table 95. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Type (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Type (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue by Country (2023-2028) & (US$ Million)
Table 105. Research Foundation for Microbial Diseases of Osaka University Corporation Information
Table 106. Research Foundation for Microbial Diseases of Osaka University Description and Major Businesses
Table 107. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 108. Research Foundation for Microbial Diseases of Osaka University Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Research Foundation for Microbial Diseases of Osaka University Recent Developments
Table 110. Valneva Austria GmbH Corporation Information
Table 111. Valneva Austria GmbH Description and Major Businesses
Table 112. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 113. Valneva Austria GmbH Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Valneva Austria GmbH Recent Developments
Table 115. Chengdu Institute Corporation Information
Table 116. Chengdu Institute Description and Major Businesses
Table 117. Chengdu Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 118. Chengdu Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Chengdu Institute Recent Developments
Table 120. Liaoning Dacheng Corporation Information
Table 121. Liaoning Dacheng Description and Major Businesses
Table 122. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 123. Liaoning Dacheng Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. Liaoning Dacheng Recent Developments
Table 125. Wuhan Institute Corporation Information
Table 126. Wuhan Institute Description and Major Businesses
Table 127. Wuhan Institute Japanese Encephalitis Virus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 128. Wuhan Institute Japanese Encephalitis Virus Vaccine Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Wuhan Institute Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Japanese Encephalitis Virus Vaccine Distributors List
Table 133. Japanese Encephalitis Virus Vaccine Customers List
Table 134. Japanese Encephalitis Virus Vaccine Market Trends
Table 135. Japanese Encephalitis Virus Vaccine Market Drivers
Table 136. Japanese Encephalitis Virus Vaccine Market Challenges
Table 137. Japanese Encephalitis Virus Vaccine Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Japanese Encephalitis Virus Vaccine Product Picture
Figure 3. Global Japanese Encephalitis Virus Vaccine Market Share by Type in 2021 & 2028
Figure 3. Inactivated Vaccine Product Picture
Figure 4. Live Attenuated Vaccine Product Picture
Figure 5. Global Japanese Encephalitis Virus Vaccine Market Share by Application in 2021 & 2028
Figure 6. Public
Figure 7. Private
Figure 8. Japanese Encephalitis Virus Vaccine Report Years Considered
Figure 9. Global Japanese Encephalitis Virus Vaccine Sales 2017-2028 (K Units)
Figure 10. Global Japanese Encephalitis Virus Vaccine Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 11. Global Japanese Encephalitis Virus Vaccine Revenue 2017-2028 (US$ Million)
Figure 12. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 13. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2017-2022)
Figure 14. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Region (2023-2028)
Figure 15. North America Japanese Encephalitis Virus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 16. North America Japanese Encephalitis Virus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 17. Europe Japanese Encephalitis Virus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 18. Europe Japanese Encephalitis Virus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Asia-Pacific Japanese Encephalitis Virus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 20. Asia-Pacific Japanese Encephalitis Virus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Latin America Japanese Encephalitis Virus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 22. Latin America Japanese Encephalitis Virus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Middle East & Africa Japanese Encephalitis Virus Vaccine Sales YoY (2017-2028) & (K Units)
Figure 24. Middle East & Africa Japanese Encephalitis Virus Vaccine Revenue YoY (2017-2028) & (US$ Million)
Figure 25. The Japanese Encephalitis Virus Vaccine Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 26. The Top 5 and 10 Largest Manufacturers of Japanese Encephalitis Virus Vaccine in the World: Market Share by Japanese Encephalitis Virus Vaccine Revenue in 2021
Figure 27. Global Japanese Encephalitis Virus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 28. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 29. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 30. Global Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 31. Global Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 32. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 33. North America Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 34. North America Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 35. North America Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 36. North America Japanese Encephalitis Virus Vaccine Sales Share by Country (2017-2028)
Figure 37. North America Japanese Encephalitis Virus Vaccine Revenue Share by Country (2017-2028)
Figure 38. the United States Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 39. Canada Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 40. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 41. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 42. Europe Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 43. Europe Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 44. Europe Japanese Encephalitis Virus Vaccine Sales Share by Country (2017-2028)
Figure 45. Europe Japanese Encephalitis Virus Vaccine Revenue Share by Country (2017-2028)
Figure 46. Germany Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 47. France Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 48. UK Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 49. Italy Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 50. Russia Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 51. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 52. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 53. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 55. Asia Pacific Japanese Encephalitis Virus Vaccine Sales Share by Region (2017-2028)
Figure 56. Asia Pacific Japanese Encephalitis Virus Vaccine Revenue Share by Region (2017-2028)
Figure 57. China Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 58. Japan Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 59. South Korea Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 60. India Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 61. Australia Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 62. China Taiwan Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 63. Indonesia Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 64. Thailand Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 65. Malaysia Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 66. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 67. Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 68. Latin America Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 69. Latin America Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 70. Latin America Japanese Encephalitis Virus Vaccine Sales Share by Country (2017-2028)
Figure 71. Latin America Japanese Encephalitis Virus Vaccine Revenue Share by Country (2017-2028)
Figure 72. Mexico Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 73. Brazil Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 74. Argentina Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 75. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Market Share by Type (2017-2028)
Figure 77. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Market Share by Application (2017-2028)
Figure 78. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Japanese Encephalitis Virus Vaccine Sales Share by Country (2017-2028)
Figure 80. Middle East and Africa Japanese Encephalitis Virus Vaccine Revenue Share by Country (2017-2028)
Figure 81. Turkey Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 82. Saudi Arabia Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 83. UAE Japanese Encephalitis Virus Vaccine Revenue (2017-2028) & (US$ Million)
Figure 84. Japanese Encephalitis Virus Vaccine Value Chain
Figure 85. Japanese Encephalitis Virus Vaccine Production Process
Figure 86. Channels of Distribution
Figure 87. Distributors Profiles
Figure 88. Bottom-up and Top-down Approaches for This Report
Figure 89. Data Triangulation
Figure 90. Key Executives Interviewed
Industry Market Size
